Device Digest

Emmes Expands its Portfolio by Acquiring Essex Management, a Tech Pioneer Facilitating Cutting-Edge Clinical Research

Emmes, an international full-service Clinical Research Organization (CRO) committed to promoting public health and biopharmaceutical breakthroughs, recently revealed its acquisition of Essex Management. Essex delivers bioinformatics and health information technology (HIT) consulting services to governmental, private sector, and academic institutions. Marking its sixth acquisition in just over two years, Emmes continues to pursue growth by […]

Drug Updates

Emmes launches Orphan Reach™: Emmes’ Rare Disease Center

Emmes – a full service, global clinical research organization (CRO) – is launching its new center, Orphan Reach™ as a unique ‘rare CRO’. The new rare disease center will incorporate Emmes’ world class reputation in public health research across the public sector and biopharmaceutical industry, with the expertise of Orphan Reach, a UK-based specialty CRO acquired by Emmes […]